MENU
ADUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ADUS stock forecast, quote, news & analysis

Addus HomeCare Corp is engaged in the provision of in-home care services... Show more

ADUS
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for ADUS with price predictions
Sep 11, 2026

ADUS sees its Stochastic Oscillator climbs out of oversold territory

On September 03, 2026, the Stochastic Oscillator for ADUS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In 45 of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for ADUS moved above the 200-day moving average on August 13, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +0.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 213 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 122 of 206 cases where ADUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADUS as a result. In 57 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.904) is normal, around the industry mean (238.721). P/E Ratio (20.506) is within average values for comparable stocks, (132.225). Projected Growth (PEG Ratio) (1.028) is also within normal values, averaging (1.624). ADUS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (1.465) is also within normal values, averaging (2.673).

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.86B. The market cap for tickers in the group ranges from 48.5K to 92.43B. HCA holds the highest valuation in this group at 92.43B. The lowest valued company is BYZN at 48.5K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 33%. CMPS experienced the highest price growth at 8%, while WW experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was -38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 46
Price Growth Rating: 50
SMR Rating: 66
Profit Risk Rating: 87
Seasonality Score: -34 (-100 ... +100)
View a ticker or compare two or three
ADUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of home and community based services

Industry HospitalNursingManagement

Profile
Details
Industry
Medical Or Nursing Services
Address
6303 Cowboys Way
Phone
+1 469 535-8200
Employees
50659
Web
https://www.addus.com
ADUS sees its Stochastic Oscillator climbs out of oversold territory